Intradermal Trivalent Influenza Vaccine With Imiquimod

NACompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Chronic Illness
Interventions
BIOLOGICAL

influenza vaccine

single dose of intradermal 15 mcg non-adjuvanted 2011/2012 trivalent influenza vaccine

DRUG

Imiquimod

pretreatment with topical imiquimod cream to the injection site before vaccination

BIOLOGICAL

influenza vaccine

single dose of intradermal 15mcg non-adjuvanted 2011/2012 trivalent influenza vaccine

DRUG

Aqueous cream

pretreatment with topical aqueous cream to the injection site before vaccination

BIOLOGICAL

influenza vaccine

single dose of intramuscular 15mcg non-adjuvanted 2011/2012 trivalent influenza vaccine

DRUG

Aqueous cream

pretreatment with topical aqueous cream to the injection site before vaccination

Trial Locations (1)

Unknown

The University of Hong Kong, Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT01508884 - Intradermal Trivalent Influenza Vaccine With Imiquimod | Biotech Hunter | Biotech Hunter